OPEN Health Appoints David Sakadelis as Chief Technology Officer
February 5, 2025 |
OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for biopharma partners, focusing on solving challenges and driving innovation in our Solution Innovation Center.
February 5, 2025, London, UK – OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for biopharma partners, focusing on solving challenges and driving innovation in our Solution Innovation Center.
OPEN Health’s Solution Innovation Center (SIC) consists of a cross-functional team that leverages technology partnerships to combine scientific expertise and proprietary product development to advance biopharmaceutical innovation in Medical Affairs and market access.
An experienced executive with over 25 years of expertise, including 13 years in biopharma with Publicis Health and Klick Health, David has led a wide range of projects. Notably, he spearheaded the development of connected patient services using innovative tools that address patient adherence and enhance patient-doctor communication. This suite of services has been recognized as a significant advancement for biopharma in patient engagement and stands as a testament to David’s ability to effectively apply technology to addressing healthcare needs.
In addition to his work on connected patient services, David has led the strategy and technical implementation for transformative content production that revolutionized the way high-volume content is produced by incorporating AI and automation, significantly reducing production costs and improving efficiency. He has also played a critical role in developing platforms designed to enhance engagement at medical congresses through real-time insights and personalized experiences.
“David’s strategic vision, technical acumen, and passion for leveraging technology to solve complex business challenges make him an ideal fit for OPEN Health,” said Steve Duryee, Chief Operating and Transformation Officer of OPEN Health. “We are excited to have him on board as he brings his expertise in IT, healthcare experience, and growth strategy to drive transformational change.”
“I am excited to join OPEN Health at such a pivotal moment, where technology and innovation are key to advancing biopharmaceutical companies,” said David. “I look forward to working with the talented team here to create impactful, technology-driven tools that address some of the most pressing challenges in Medical Affairs and market access. Together, we will continue to push the boundaries of what’s possible, delivering tangible value for our biopharma partners and improving patient outcomes globally.”
About OPEN Health
OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. To learn more, visit www.openhealthgroup.com
Contact:
Candice Subero, VP of Global Marketing
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health’s response to the FDA’s guidance on long term follow up post gene therapy
Written by Gavin Jones, OPEN Health
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy
OPEN Health becomes sponsor of MedComms Networking
New for 2020, OPEN Health is pleased to announce its sponsorship of MedComms Networking
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.
Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?
A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....
Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma
OPEN Health reflections on the World Orphan Drug Congress in Barcelona
Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...